To identify nationwide trends in hemostatic agent (HA) use during outpatient benign hysterectomy between October 2015 and December 2019. Using Current Procedural Terminology codes captured the Vizient Clinical Data Base, a national encounter-based dataset, female patients of at least 18 years who underwent an 2019 were identified. An HA is topically applied procoagulant product was determined b...

The present study evaluated the hemostatic efficacy and handling of gelatin-thrombin matrix hemostatic sealant during intracranial procedures. A retrospective analysis of 478 consecutive patients undergoing intracranial procedures identified seven patients with acute intense or persistent intraoperative bleeding which could not be arrested in time by standard hemostatic methods. The efficacy of...

Background/Aim: Nowadays, many deaths are related to vessel injury-induced blood loss. Failure control bleeding also increases the risk of death. This study aimed investigate hemostatic effects Algan Hemostatic Agent (AHA) foam application in a rat model which severe femoral artery was induced.
 Methods: Fourteen rats were randomly assigned two groups: (1) (physiological saline) (n = 7) an...